Cargando…

Effect of Food on the Pediatric Dispersible Tablet Formulations of TRIUMEQ and DOVATO in Healthy Adult Participants

This randomized food effect study in healthy adult participants examined dispersible tablet formulations of fixed-dose combinations of dolutegravir/abacavir/lamivudine (TRIUMEQ) and dolutegravir/lamivudine (DOVATO). While adult tablet formulations of these combinations are currently approved for the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chandasana, Hardik, Marnoch, Ryan, McKenna, Michael, Double, Julia, Seal, Ciara, Bontempo, Gilda, Wolstenholme, Allen, Buchanan, Ann
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224436/ https://www.ncbi.nlm.nih.gov/pubmed/37242711 http://dx.doi.org/10.3390/pharmaceutics15051470

Ejemplares similares

1593. Switch to DOVATO in Patients Suppressed on Biktarvy (The SOUND Study), week 48 interim analysis
por: Slim, Jihad, et al.
Publicado: (2023)

Formulation and Evaluation of Loperamide HCl Oro Dispersible Tablets
por: Alejandro, Blasco, et al.
Publicado: (2020)

High Acceptability of an Orally Dispersible Tablet Formulation by Children
por: Wagner-Hattler, Leonie, et al.
Publicado: (2021)

Efficacy and safety of the switch of Triumeq® to generic (abacavir + lamivudine) + Tivicay®: data at 24 weeks
por: Olalla, Julián, et al.
Publicado: (2018)

Formulation and evaluation of fast dissolving tablets of haloperidol solid dispersion
por: Eisa, Aya M., et al.
Publicado: (2022)

Correction to: efficacy and safety of the switch of Triumeq® to generic (abacavir + lamivudine) + Tivicay®: data at 24 weeks
por: Olalla, Julián, et al.
Publicado: (2023)

Abacavir/Dolutegravir/Lamivudine (Triumeq)–Induced Liver Toxicity in a Human Immunodeficiency Virus–Infected Patient
por: Christensen, Erin S., et al.
Publicado: (2017)

Formulation and evaluation of microsphere based oro dispersible tablets of itopride hcl
por: Shah, Sanjay, et al.
Publicado: (2012)

Formulation and evaluation of fast dissolving tablet containing domperidone ternary solid dispersion
por: Patel, Dasharath M., et al.
Publicado: (2014)

Homogenization of Amorphous Solid Dispersions Prepared by Electrospinning in Low-Dose Tablet Formulation
por: Fülöp, Gergő, et al.
Publicado: (2018)

Case report of Triumeq (abacavir/dolutegravir/lamivudine) associated rhabdomyolysis in a human immunodeficiency virus (HIV) infected patient
por: Saad, Muhammad, et al.
Publicado: (2019)

Triumeq Increases Excitability of Pyramidal Neurons in the Medial Prefrontal Cortex by Facilitating Voltage-Gated Ca(2+) Channel Function
por: Chen, Lihua, et al.
Publicado: (2021)

Pharmacokinetics, Safety, and Tolerability of a Single Oral Dose of Abacavir/Dolutegravir/Lamivudine Combination Tablets in Healthy Japanese Study Participants
por: Singh, Rajendra P., et al.
Publicado: (2021)

Revisiting dispersible milk-drug tablets as a solid lipid formulation in the context of digestion
por: Binte Abu Bakar, Syaza Y., et al.
Publicado: (2019)

Renal Function in Patients with Thalassemia Major Receiving Exjade(®) Dispersible Tablets and a New Film-coated Tablet Formulation of Deferasirox (Nanojade(®))
por: Falahati, Vahid, et al.
Publicado: (2022)

Relative Bioavailability of a Dolutegravir Dispersible Tablet and the Effects of Low‐ and High‐Mineral‐Content Water on the Tablet in Healthy Adults
por: Buchanan, Ann M., et al.
Publicado: (2017)

Relative Bioavailability and Food Effect of GSK3640254 Tablet and Capsule Formulations in Healthy Participants
por: Johnson, Mark, et al.
Publicado: (2022)

Relative Bioavailability of Orally Dispersible Tablet Formulations of Levo‐ and Racemic Praziquantel: Two Phase I Studies
por: Bagchus, Wilhelmina Maria, et al.
Publicado: (2018)

The Molecular Link Between TDP-43, Endogenous Retroviruses and Inflammatory Neurodegeneration in Amyotrophic Lateral Sclerosis: a Potential Target for Triumeq, an Antiretroviral Therapy
por: Dubowsky, Megan, et al.
Publicado: (2023)

Development of raft-forming liquid and chewable tablet formulations incorporating quercetin solid dispersions for treatment of gastric ulcers
por: Bunlung, Suputra, et al.
Publicado: (2021)

Itraconazole Amorphous Solid Dispersion Tablets: Formulation and Compaction Process Optimization Using Quality by Design Principles and Tools
por: Triboandas, Hetvi, et al.
Publicado: (2022)

Formulation and characterization of orodispersible tablet of glimepiride
por: Kinani, Ahmad AB Yosef, et al.
Publicado: (2022)

Pandemic-Era WIC Participation in Wilmington, Delaware: Participants’ Experiences and Challenges
por: Halverson, McKenna M., et al.
Publicado: (2023)

Evaluation of two novel tablet formulations of artemether-lumefantrine (Coartem®) for bioequivalence in a randomized, open-label, two-period study
por: Lefèvre, Gilbert, et al.
Publicado: (2013)

Spectrophotometric estimation of betahistine hydrochloride in tablet formulations
por: Kumar, Amit, et al.
Publicado: (2010)

Formulation and Evaluation of Omeprazole Tablets for Duodenal Ulcer
por: Choudhury, A., et al.
Publicado: (2010)

Formulation and Evaluation of Mouth Dissolving Tablets of Cinnarizine
por: Patel, B. P., et al.
Publicado: (2010)

Formulation and evaluation of aceclofenac mouth-dissolving tablet
por: Solanki, Shailendra Singh, et al.
Publicado: (2011)

Standardization of Sulaharan Yoga: An Ayurvedic Tablet Formulation
por: Pattanayak, P., et al.
Publicado: (2011)

Formulation and evaluation of floating tablets of liquorice extract
por: Ram, H. N. Aswatha, et al.
Publicado: (2010)

Key Formulation Variables in Tableting of Coated Pellets
por: Murthy Dwibhashyam, V. S. N., et al.
Publicado: (2008)

Spectrophotometric estimation of solifenacin succinate in tablet formulations
por: Singh, Lokesh, et al.
Publicado: (2011)

Formulation and evaluation of floating matrix tablet of stavudine
por: Prajapati, Pankaj H, et al.
Publicado: (2012)

Amorphous Nanoparticulate Formulation of Sirolimus and Its Tablets
por: Shen, Yudong, et al.
Publicado: (2018)

Formulation and Evaluation of New Glimepiride Sublingual Tablets
por: Al-Madhagi, Wafa, et al.
Publicado: (2017)

Formulation and evaluation of mucoadhesive buccal tablets of aceclofenac
por: Koirala, Santosh, et al.
Publicado: (2021)

Formulation and Characterization of an Effervescent Hydrogen-Generating Tablet
por: Rosch, Moritz, et al.
Publicado: (2021)

Erratum: Formulation and characterization of orodispersible tablet of glimepiride
Publicado: (2023)

Aceclofenac fast dispersible tablet formulations: Effect of different concentration levels of Avicel PH102 on the compactional, mechanical and drug release characteristics
por: Yasmin, Riffat, et al.
Publicado: (2020)

Patient preference for deferasirox film-coated versus dispersible tablet formulation: a sequential-design phase 2 study in patients with thalassemia
por: Viprakasit, Vip, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ii0f7tfaq3cch9tnidv2llkuuk